Report: McKesson Likely to Settle Claims in Pricing Case
Bloomberg reports that drug wholesaler McKesson Corp. will likely settle damage claims of as much as $15 billion for inflating prices on prescription drugs paid by private health-benefit plans and individuals. McKesson has more than $100 billion in annual revenues. The drug distributor has denied the claims made in the lawsuit. The Bloomberg article offers good background on the case. Read it here.
Related articles from MDM:
McKesson May Face Treble Damages in Class Action ...
Report: McKesson Likely to Settle Claims in Pricing Case Read More »